Spatial mapping of barcoded, brain-tropic AAVs using multiplexed RNA in situ hybridization
Molecular Therapy Advances · 2026-03 · 34 (1) · 201693
DOI: 10.1016/j.omta.2026.201693 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Therapy Advances, 2026-03. Verfasst von Youssef Fouani und 16 weiteren Autor:innen. Beteiligte Einrichtung: Eye Health & Research Beyond Borders, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach an der Riss, Germany. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Boehringer Ingelheim.
Abstract (Originalsprache)
Gene therapy cargo delivery to specific cell types in the central nervous system (CNS) remains a major challenge for the development of adeno-associated virus (AAV) vectors as a therapeutic modality. Here, we leverage high-plex in situ transcriptomics (10× Genomics Xenium) to spatially map barcoded AAV payloads at subcellular resolution in the intact mouse brain while preserving anatomical context. Tropism profiling of 22 barcoded AAV variants including novel AAV9 derivatives and CNS-targeted capsids revealed that established vectors, AAV9-PHP.eB and AAV9-CAP-B10, demonstrated distinct neuronal and non-neuronal subtype preferences, recapitulating previous findings. Several novel AAV variants candidates predominantly transduced endothelial and vascular cells, suggesting limited blood-brain barrier (BBB) penetration. Notably, three novel variants (AAV9-BTX166, -BTX168, and -BTX175) exhibited enhanced endothelial and mural cell tropism, despite robust CNS activity in bulk assays. Intriguingly, the novel variants AAV9-BTX149 and -BTX001 displayed selective targeting of specific inhibitory neuron subtypes, with a single Trp503Arg substitution in the capsid being sufficient to redirect tropism. Our results establish in situ spatial transcriptomics as a powerful tool for resolving AAV biodistribution and BBB traversal capacities at high resolution, providing a blueprint for capsid engineering to achieve precise cell subtype targeting in the CNS.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Eye Health & Research Beyond Borders, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach an der Riss, Germany.
- Computational Innovation, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach, Germany.
- Drug Discovery Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach an der Riss, Germany.
Förderung
- Boehringer Ingelheim
Zitieren
APA
Fouani, Y., Oti, M., Jarosch, S., Blazevic, D., Duechs, M. J., Ketterer, S., Becker, R., Abele, S., Strobel, B., Schoenberger, T., Alanis-Lobato, G., Rust, W., Schoen, C., Klugmann, M., Maier, U., Doerr, J., & Michelfelder, S. (2026). Spatial mapping of barcoded, brain-tropic AAVs using multiplexed RNA in situ hybridization. Molecular Therapy Advances, 34(1), 201693. https://doi.org/10.1016/j.omta.2026.201693
Vancouver
Fouani Y, Oti M, Jarosch S, Blazevic D, Duechs MJ, Ketterer S, et al. Spatial mapping of barcoded, brain-tropic AAVs using multiplexed RNA in situ hybridization. Molecular Therapy Advances. 2026;34(1):201693. doi:10.1016/j.omta.2026.201693
BibTeX
@article{Fouani2026,
author = {Fouani, Youssef and Oti, Martin and Jarosch, Sebastian and Blazevic, Dragica and Duechs, Matthias Johannes and Ketterer, Stephanie and Becker, Robert and Abele, Sarah and Strobel, Benjamin and Schoenberger, Tanja and Alanis-Lobato, Gregorio and Rust, Werner and Schoen, Christian and Klugmann, Matthias and Maier, Udo and Doerr, Jonas and Michelfelder, Stefan},
title = {Spatial mapping of barcoded, brain-tropic AAVs using multiplexed RNA in situ hybridization},
journal = {Molecular Therapy Advances},
year = {2026},
volume = {34},
number = {1},
pages = {201693},
doi = {10.1016/j.omta.2026.201693}
}
EUVIMED